+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Hemophilia Treatment Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025

  • ID: 4841105
  • Report
  • August 2019
  • Region: Global
  • 100 pages
  • Infinium Global Research
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Baxalta
  • Baxter International
  • Bayer
  • Biogen Idec
  • CSL Ltd.
  • Grifols
  • MORE
The report on the global hemophilia treatment market provides qualitative and quantitative analysis for the period from 2017 to 2025. The report predicts the global hemophilia treatment market to grow with a CAGR of 5.3% over the forecast period from 2019-2025. The study on hemophilia treatment market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2017 to 2025.

The report on hemophilia treatment market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global hemophilia treatment market over the period of 2017 to 2025. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global hemophilia treatment market over the period of 2017 to 2025. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings

1) Drivers
  • The rising prevalence rate of bleeding disorder and their increasing severity, the increasing research activities and advancing medical knowledge
  • The rising use of prophylactic treatment in hemophilia, technological advancements, the invention of new coagulating factors, flourishing biotechnology filed
2) Restraints
  • The growing adoption of vegetarian food and increasing storage and maintenance cost of the vaccine
3) Opportunities
  • Rising awareness among people, escalating r&d focused on identifying curative agents
Research Methodology

A) Primary Research
Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
1. Key Opinion Leaders associated with Author
2. Internal and External subject matter experts
3. Professionals and participants from the industry

Our primary research respondents typically include
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.

B) Secondary Research
Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include
1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered
The global hemophilia treatment market is segmented on the basis of type, product, and therapy.

The Global Hemophilia Treatment Market by Type
  • Hemophilia A
  • Hemophilia B
  • Hemophilia C
The Global Hemophilia Treatment Market by Product
  • Plasma Derived Coagulation Factor Concentrates
  • Desmopressin
  • Recombinant Coagulation Factor Concentrates
  • Antifibrinolytic Agents
The Global Hemophilia Treatment Market by Therapy
  • ITI Therapy
  • Gene Therapy
  • Replacement Therapy
Company Profiles
The companies covered in the report include
  • Pfizer
  • Baxter International
  • Grifols
  • CSL Ltd.
  • Baxalta
  • Octapharma
  • Novo Nordisk
  • Bayer
  • Hospira
  • Biogen Idec
What does this report deliver?
1. Comprehensive analysis of the global as well as regional markets of the hemophilia treatment market.
2. Complete coverage of all the segments in the hemophilia treatment market to analyze the trends, developments in the global market and forecast of market size up to 2025.
3. Comprehensive analysis of the companies operating in the global hemophilia treatment market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Baxalta
  • Baxter International
  • Bayer
  • Biogen Idec
  • CSL Ltd.
  • Grifols
  • MORE
1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches

2. Executive Summary
2.1. Hemophilia Treatment Market Highlights
2.2. Hemophilia Treatment Market Projection
2.3. Hemophilia Treatment Market Regional Highlights

3. Global Hemophilia Treatment Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. Growth Matrix Analysis
3.4.1. Growth Matrix Analysis by Type
3.4.2. Growth Matrix Analysis by Product
3.4.3. Growth Matrix Analysis by Therapy
3.4.4. Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Hemophilia Treatment Market

4. Hemophilia Treatment Market Macro Indicator Analysis

5. Global Hemophilia Treatment Market by Type
5.1. Hemophilia A
5.2. Hemophilia B
5.3. Hemophilia C

6. Global Hemophilia Treatment Market by Product
6.1. Plasma Derived Coagulation Factor Concentrates
6.2. Desmopressin
6.3. Recombinant Coagulation Factor Concentrates
6.4. Antifibrinolytic Agents

7. Global Hemophilia Treatment Market by Therapy
7.1. ITI Therapy
7.2. Gene Therapy
7.3. Replacement Therapy

8. Global Hemophilia Treatment Market by Region 2019-2025
8.1. North America
8.1.1. North America Hemophilia Treatment Market by Type
8.1.2. North America Hemophilia Treatment Market by Product
8.1.3. North America Hemophilia Treatment Market by Therapy
8.1.4. North America Hemophilia Treatment Market by Country
8.2. Europe
8.2.1. Europe Hemophilia Treatment Market by Type
8.2.2. Europe Hemophilia Treatment Market by Product
8.2.3. Europe Hemophilia Treatment Market by Therapy
8.2.4. Europe Hemophilia Treatment Market by Country
8.3. Asia-Pacific
8.3.1. Asia-Pacific Hemophilia Treatment Market by Type
8.3.2. Asia-Pacific Hemophilia Treatment Market by Product
8.3.3. Asia-Pacific Hemophilia Treatment Market by Therapy
8.3.4. Asia-Pacific Hemophilia Treatment Market by Country
8.4. RoW
8.4.1. RoW Hemophilia Treatment Market by Type
8.4.2. RoW Hemophilia Treatment Market by Product
8.4.3. RoW Hemophilia Treatment Market by Therapy
8.4.4. RoW Hemophilia Treatment Market by Sub-region

9. Company Profiles and Competitive Landscape
9.1. Competitive Landscape in the Global Hemophilia Treatment Market
9.2. Companies Profiles
9.2.1. Pfizer
9.2.2. Baxter International
9.2.3. Grifols
9.2.4. CSL Ltd.
9.2.5. Baxalta
9.2.6. Octapharma
9.2.7. Novo Nordisk
9.2.8. Bayer
9.2.9. Hospira
9.2.10. Biogen Idec

10. Appendix
10.1. Primary Research Findings and Questionnaire
Note: Product cover images may vary from those shown
3 of 3
  • Pfizer
  • Baxter International
  • Grifols
  • CSL Ltd.
  • Baxalta
  • Octapharma
  • Novo Nordisk
  • Bayer
  • Hospira
  • Biogen Idec
Note: Product cover images may vary from those shown
Adroll
adroll